Ik-Hwan Han

9PUBLICATIONS
12CO-AUTHORS
Medical mycologyMolecular targetsMedical infection agents (incl. prions)Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Aug 21, 2026
Melittin Reprograms Tumor-Associated Macrophages Through CD18-Mediated Immunomodulation.

|Jun 13, 2025
The Combination of CD300c Antibody with PD-1 Blockade Suppresses Tumor Growth and Metastasis by Remodeling the Tumor Microenvironment in Triple-Negative Breast Cancer.

Soyoung Kim, Ik-Hwan Han, Suin Lee

|Dec 23, 2022
Enhanced Therapeutic Effect of Optimized Melittin-dKLA, a Peptide Agent Targeting M2-like Tumor-Associated Macrophages in Triple-Negative Breast Cancer.

Soyoung Kim, Ilseob Choi, Ik-Hwan Han

|Mar 25, 2022
Therapeutic Effect of Melittin-dKLA Targeting Tumor-Associated Macrophages in Melanoma.

Ik-Hwan Han, Chanmi Jeong, Juwon Yang

|May 15, 2021
Mast cell tryptase-PAR2 pathway in proliferation of prostatic stromal cells reacted with Trichomonas vaginalis.

Chang-Suk Noh, Hyo-Yeoung Chung, Ik-Hwan Han

|Apr 03, 2021
Magnoliae Cortex Alleviates Muscle Wasting by Modulating M2 Macrophages in a Cisplatin-Induced Sarcopenia Mouse Model.

Minwoo Hong, Ik-Hwan Han, Ilseob Choi

Pageof 2

Frequent Collaborators

6 joint publications

Hyunsu Bae

3 joint publications

Jae-Sook Ryu

3 joint publications

Soyoung Kim

2 joint publications

Ilseob Choi